title: Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study.
authors.affiliation: US OncologyVirginia Cancer Specialists, 8503 Arlington Blvd, #400, Fairfax, VA, USA. Nicholas.Robert@usoncology.com
authors.forename: Nicholas
authors.initials: N
authors.lastname: Robert
authors.forename: Lea
authors.initials: L
authors.lastname: Krekow
authors.forename: Chris
authors.initials: C
authors.lastname: Stokoe
authors.forename: Alicia
authors.initials: A
authors.lastname: Clawson
authors.forename: Jose
authors.initials: J
authors.lastname: Iglesias
authors.forename: Joyce
authors.initials: J
authors.lastname: O'Shaughnessy